Preparing Medical Devices For PFAS-Free Coatings

Preparing Medical Devices For PFAS Free Coatings

Few people think about the thin layer of material on a guidewire or a surgical blade. Yet that coating shapes how a device performs. It helps a wire glide smoothly through a blood vessel, stops tissue from sticking to an electrosurgical tool and keeps electrical current where it belongs. For decades, fluoropolymers such as PTFE have been the default choice for many of these jobs because they are slippery, stable and reliable.

That default is now being questioned. PFAS, the large family of fluorinated chemicals that PTFE belongs to, face growing scrutiny from regulators, hospital buyers and the public. Medical device makers are being asked a question they rarely faced before: could this product work just as well with a different coating?

Answering it takes planning, testing and time. Companies that start early will have far more room to make good decisions than those that wait for a deadline.

Why Coatings Matter So Much

Coatings on medical devices do several jobs at once. The most common include:

Lubricity, so wires, catheters and mandrels move smoothly with less friction.

Non-stick performance, so blades, forceps and jaws release tissue cleanly.

Electrical insulation, so energy-based tools deliver current only where intended.

Durability, so the surface holds up through handling, use and, for reusable tools, repeated cleaning.

A change to any one of these properties can affect how a clinician experiences the device. A guidewire that feels slightly different in the hand can change a procedure. That is why coating decisions are rarely simple swaps.

The Pressure Behind The Shift

Concern about PFAS has grown because some of these chemicals persist in the environment for a very long time. Certain older processing aids, such as PFOA and PFOS, have already been phased out of many manufacturing processes. Broader restrictions covering the wider PFAS family are being discussed in several regions, and the details continue to change.

Medical devices are often treated carefully in these discussions because patient safety comes first and alternatives are not always ready. Still, many manufacturers would rather not bet their product lines on future exemptions. Hospital systems are also paying closer attention to the materials in what they buy. Together, these pressures make PFAS-free options worth exploring now, even for devices that will keep using fluoropolymers for some time.

Start With A Clear Device Inventory

The first practical step is knowing where coatings are used across the product portfolio. Many companies discover that coated components appear in more places than they expected, from guidewires and hypotubes to needles, probes, push and pull wires and even molds and dies used in production.

For each coated part, it helps to record:

The coating currently used.

The property it provides.

Whether the device is disposable or reusable.

The supplier and specification.

How critical the coating is to clinical performance.

This inventory shows which products could move to an alternative quickly and which would need extensive testing. A non-stick coating on a manufacturing mold is a very different challenge from the lubricious layer on a coronary guidewire.

Match Performance, Not Just Materials

Switching coatings works best when teams focus on the job the coating does rather than the chemical it contains. If a coating’s main role is insulation, the alternative must insulate just as reliably. If lubricity is the priority, friction testing becomes central.

Formulations also differ in how they are applied. Some are aqueous-based and others are solvent-based. Some suit continuous reel-to-reel coating of fine wire, while others work better on discrete lengths or finished assemblies. Wire diameter, device geometry and the stage of assembly at the time of coating all influence which options are realistic. A coating that performs beautifully on a straight mandrel may behave differently on a coiled guidewire with welded internal wires.

Biocompatibility is non-negotiable. Any new coating has to meet the safety requirements for its intended contact with the body, and that usually means fresh testing and documentation.

Prototype Early And Test Thoroughly

Coating changes should move through the same careful steps as any design change. Small prototype runs let engineers compare alternatives side by side before committing. Bench tests can measure adhesion, uniformity, coating thickness, friction and electrical properties. Simulated-use testing shows how the device behaves in conditions closer to real procedures.

Verification matters just as much at scale. A coating that looks perfect on ten prototypes must stay consistent across thousands of production parts. Automated application methods help deliver repeatable, uniform results from one part to the next, and inspection against the coating specification confirms that each batch meets requirements.

Regulatory planning should run alongside testing, not after it. Depending on the device and market, a material change may require additional documentation or submissions. Building that time into the project plan avoids surprises late in the process.

Choose Coating Partners Carefully

Few device makers apply every coating themselves. Most rely on specialist applicators, and the choice of partner can make the transition much smoother. Useful questions include:

How many coating options are available, including PFAS-free formulations?

Can they support prototypes, short runs and high volumes?

What range of wire diameters and lengths can they handle?

Can they coat devices at different stages of assembly?

How do they verify that every part meets specification?

What technical guidance do they offer when choosing a coating?

Many companies compare several providers, from in-house options to outside specialists, and Surface Solutions Group medical device coating services is one example of the kind of supplier worth evaluating on those criteria. A partner that offers both fluoropolymer and PFAS-free options can be especially helpful during a gradual transition, since many portfolios will run both for years.

Plan For A Gradual Transition

Very few companies can switch every coated product at once, and most should not try. A phased approach usually works better. Start with lower-risk applications, such as manufacturing tools or non-critical components, where testing is simpler. Use those projects to build experience and data. Then move on to devices where coating performance is more closely tied to clinical outcomes.

Keeping current, validated coatings in place while alternatives are tested protects patients and keeps products on the market. The goal is steady progress, not a rushed change that creates new risks.

Getting Ahead Of The Change

The surface of a medical device may be measured in microns, but it carries a great deal of responsibility. As expectations around PFAS continue to shift, device makers that map their coatings, test alternatives early and work closely with experienced coating partners will be ready for whatever rules arrive next. Planning now keeps the focus where it belongs: on devices that perform safely and reliably for every patient.

0 Shares:
You May Also Like